MichaelPatrickKeithMD
Rheumatology • Vienna, VAProfessor of Medicine, Uniformed Services University SOM
Dr. Keith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8100 Boone Blvd
Ste 700
Vienna, VA 22182Phone+1 571-423-5699Fax+1 571-423-5698
Summary
- Dr. Michael Keith is a rheumatologist based in Vienna, VA. He completed both his internal medicine residency and rheumatology fellowship at the National Capital Consortium. Dr. Keith is a well-published expert within his field, holding notable contributions in the Journal of Clinical Rheumatology, BMJ Case Reports, Annals of the Rheumatic Diseases and the Journal of Autoimmunity. His most cited work is in the field of systemic lupus erythematosus (SLE). He has received fellow status from both the American College of Physicians and the American College of Rheumatology.
Education & Training
National Capital ConsortiumFellowship, Rheumatology, 2004 - 2006- National Capital ConsortiumResidency, Internal Medicine, 1998 - 2000
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1997
Certifications & Licensure
VA State Medical License 1998 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Physicians
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 175 citationsAltered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.Melissa E. Munroe, Rufei Lu, Yan D. Zhao, Dustin A. Fife, Julie M. Robertson
Annals of the Rheumatic Diseases. 2016-01-25 - 114 citationsDysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.Rufei Lu, Melissa E. Munroe, Joel M. Guthridge, Krista Bean, Dustin A. Fife
Journal of Autoimmunity. 2016-11-01 - 12 citationsNovel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.Zachary Junga, Rodger S. Stitt, Christopher L. Tracy, Michael P. Keith
BMJ Case Reports. 2017-08-21
Professional Memberships
- Fellow
- Fellow and Past Chapter Governor
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
